What researchers published on Zsírmáj (MASLD/MASH)
40 461 papers, newest first.
Showing 80 of 40 461
All-cause mortality across cryptogenic steatotic liver disease and MASLD phenotypes: an NHANES III cohort study.Endocrine
ÁttekintésBiomarkers to assess early signs of fibro-inflammatory disease modification following short-term therapeutic intervention in people living with MASLD/MASH: A systematic scoping review.PloS one
ÁttekintésStage-predominant epigenetic framework across the MASLD spectrum: global evidence and the Saudi Arabian context.Epigenomics
How low can you go? Is lower-dose vitamin E effective and safe for MASH?Hepatology (Baltimore, Md.)
Mediation Analysis of Inflammatory Biomarkers in the Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Sarcopenia Among US Adults With Type 2 Diabetes or Prediabetes.International journal of endocrinology
Finding the hidden epidemic: screening for metabolic dysfunction-associated steatotic liver disease.Proceedings (Baylor University. Medical Center)
Two drugs, one liver: A real-world test of GLP-1 RA and SGLT-2i combination therapy in MASLD.Hepatology (Baltimore, Md.)
ÁttekintésHepatic metabolic plasticity: From physiological adaptation to energy overload-associated pathological progression and therapeutic targeting.Journal of physiology and biochemistry
Integrative transcriptomic and single-nucleus analyses identify microbiota-metabolite-associated immune signatures of fibrosis severity in MASLD.PloS one
Proteome-Wide Genetic Study Identified ENTPD5 as a Candidate Target for Obesity-Related MASLD.Obesity (Silver Spring, Md.)
Cold-Shock-Primed Lactobacillus rhamnosus GG Extracellular Vesicles Restore Liver-Gut Axis Homeostasis Through Bile Acid Metabolic Reprogramming in MASLD.Journal of extracellular vesicles
Analysis of drug development risks for metabolic dysfunction-associated steatotic liver disease from a sustainable accounting perspective.Cost effectiveness and resource allocation : C/E
The prevalence of metabolic syndrome in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of observational studies.Sage open chronic disease
ÁttekintésUltrasound quantification of liver fat in MASLD.European radiology
Human placenta extract declines fat deposition in an in vitro novel 3D MASLD model.In vitro models
Carbon Dots Derived from Carbonized Citri Reticulatae Pericarpium (Chenpi) Alleviate Metabolic Dysfunction-Associated Steatohepatitis.Molecules (Basel, Switzerland)
Reply to Khan and Shoro: Endoscopic ultrasound strain elastography in metabolic dysfunction-associated steatotic liver disease: Evaluation against transient elastography and non-invasive markers.Hepatology forum
Randomizált vizsgálatEffects of Whole "Navelina" Orange Consumption on Glucose Homeostasis and Fructosamine Levels in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Randomized Controlled Trial.Nutrients
ÁttekintésThe role and mechanisms of the vascular microenvironment in metabolic dysfunction- associated fatty liver disease.Frontiers in endocrinology
Early Metabolic and Cardiovascular Alterations in Adolescents with MASLD or Simple Obesity.Nutrients
Integrated Cardiovascular-Kidney-Metabolic Disease Burden in Mexico: Trends from 2000 to 2023 and Projections to 2050.Annals of global health
Growth Hormone Reduces Liver Tumor Development in a MASLD-Related HCC Murine Model.International journal of molecular sciences
Renal Multiparametric MRI for Early Detection and Longitudinal Monitoring of Metabolic Dysfunction Associated Steatotic Liver Disease Associated Kidney Injury: Histopathologic Validation and Multi-Omics Profiling.Journal of magnetic resonance imaging : JMRI
Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease: Context, Measurement, and Treatment.Journal of clinical medicine
ÁttekintésNavigating MASLD heterogeneity: from metabolic risk to precision stratification.Frontiers in medicine
Gut microbiota dysbiosis and altered short-chain fatty acid biosynthetic pathways in Chinese children with obesity and nonalcoholic fatty liver disease.Frontiers in endocrinology
MetaanalízisSilymarin-Based Therapies in Chronic Liver Disease: A Systematic Review of Biochemical, Cardiometabolic, Steatosis, and Fibrosis-Related Outcomes.Nutrients
Network toxicology, molecular docking and in vitro validation reveal the molecular mechanisms of bisphenol A-induced MASLD.Frontiers in pharmacology
Circadian Rhythm-Related Characteristics and Adiposity in Relation to CAP-Defined Hepatic Steatosis Among Shift and Non-Shift Workers: A Pilot Study.Nutrients
Short- and Medium-Chain Fatty Acid Profiles in Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study.Nutrients
Chronic Consumption of Ghee (Clarified Butter) and Coconut Oil, but Not Palmolein, Induces Microvesicular Steatosis, Insulin Resistance, and Inflammation in Mice Fed a High-Fat Diet.Nutrients
Association Between Free Triiodothyronine and Metabolic Dysfunction-Associated Steatotic Liver Disease in Euthyroid Population: Evidence from NHANES 2007-2012.Healthcare (Basel, Switzerland)
Transcriptomic Profiling Identifies Hub Transcription Factors Associated with the Protective Effects of Licochalcone A Against HFD-Induced MASLD.Nutrients
Szisztematikus áttekintésUltra-Processed Food Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Evidence Synthesis, Methodological Appraisal, and Mechanistic Insights.Nutrients
ÁttekintésNutritional Impairment and Muscle Health in MASLD: The Potential Role of Eating Behaviors.Journal of clinical medicine
Multiparametric 0.4-T low-field MRI mapping for metabolic dysfunction-associated steatotic liver disease in rats.European radiology experimental
Altered Hepatic Hydrogen Sulfide-Related Homeostasis in Metabolic Dysfunction-Associated Steatotic Liver Disease and Its Changes Following Sleeve Gastrectomy.Journal of clinical medicine
ÁttekintésStatins and the Lifetime Outcomes of MASLD: From Evidence Asymmetry to Outcome Convergence.International journal of molecular sciences
Bacillus megaterium 1259 Limits Hepatic Lipid Accumulation in Mice with Established Diet-Induced Obesity: Paired Hepatic Transcriptomic and Metabolomic Profiling.Nutrients
MetaanalízisLarge-Scale Transcriptomic Meta-Analysis of Mouse Liver Responses to High-Fat Diet Identifies a Reproducible Core and Duration-Associated Variation.International journal of molecular sciences
ÁttekintésTrained Immunity and Persistent Myeloid Responsiveness in MASH.Cells
ÁttekintésMitochondrial Fatty Acid Oxidation Dysregulation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Roles and Emerging Diagnostic and Therapeutic Advances.Pharmacological research
MRI-Derived Muscle Composition and Visceral Adiposity in Relation to Mortality and Vascular Outcomes in MASLD.Diagnostics (Basel, Switzerland)
Response to "Endoscopic ultrasound strain elastography in metabolic dysfunction-associated steatotic liver disease: Evaluation against transient elastography and non-invasive markers".Hepatology forum
Integrated chemical profiling and lipidomics reveal that Mailuoning oral liquid alleviates diet-induced MASLD via PPARα-mediated lipid homeostasis and COX-2 inhibition, with identification of potential active constituents.Frontiers in pharmacology
Low-intensity pulsed ultrasound ameliorates diet-induced MASLD with hepatic lipid metabolic remodeling.Biochimica et biophysica acta. Molecular basis of disease
Early Sugar Exposure and the Lifelong Prevention of MASLD.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Association between systemic immune-inflammation index and skeletal muscle mass in patients with nonalcoholic fatty liver disease: A cross-sectional study.Medicine
Tubastatin A Mitigates Lipotoxicity, Inflammation and Fibrosis Through Downregulation of HDAC6 and Modulation of AMPK-FGF21 Axis in Metabolic Dysfunction-Associated Steatohepatitis.Inflammation
Metabolic Dysfunction-Associated Steatotic Liver Disease, With and Without Increased Alcohol Intake, and Incident Atrial Fibrillation in Older Korean Adults: A Competing-Risk Cohort Study.Geriatrics & gerontology international
Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic burden with urinary tubular biomarker abnormalities: a cross-sectional health examination study.Frontiers in medicine
Direct Remnant Lipoprotein Profiling Reveals Subfraction-Level Associations with Biopsy-Proven MASH in Severe Obesity.Journal of lipid research
Elevated malonic acid and 15d-PGJ2 in MASLD rats with diabetes triggered pathological cardiac remodeling through impairment of mitochondrial health and cellular metabolism.Journal of molecular and cellular cardiology
Targeting FSP1 to Suppress PI3K/AKT Signaling: Enarodustat Ameliorates MASH via Ferroptosis Inhibition and Lipid Metabolism Regulation.European journal of pharmacology
Szisztematikus áttekintésKetogenic Diet Effects on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review.Liver international : official journal of the International Association for the Study of the Liver
ÁttekintésNutraceuticals for the prevention of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD).Food science and biotechnology
ÁttekintésNatural Bioactive Compounds Targeting Lipid Metabolism in Metabolic Dysfunction-Associated Steatotic Liver Disease.Phytotherapy research : PTR
Reply to Comments to Diagnostic Value and Influencing Factors of Ultrasound-Derived Fat Fraction for Quantifying MASLD in Children.Liver international : official journal of the International Association for the Study of the Liver
ÁttekintésCompositional diversity and dietary implications of cereal and legume crops as functional resources for non-alcoholic fatty liver disease prevention: a review.Food science and biotechnology
Association of longitudinal serum 25-hydroxyvitamin D trajectories with subsequent liver stiffness increase in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.Frontiers in endocrinology
Total-Body 18F-FAPI PET/CT for Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Study.Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ÁttekintésTherapeutic opportunities of fecal microbiota transplantation in the treatment of non-alcoholic fatty liver disease.Frontiers in cellular and infection microbiology
ATM safeguards liver homeostasis by mitigating mitochondrial hypermetabolism and bioenergetic crisis in MASLD.EMBO molecular medicine
Áttekintés[Research progress on male reproductive function impairment caused by metabolic dysfunction-associated steatotic liver disease].Zhonghua nan ke xue = National journal of andrology
Correction: Prevalence and steatosis severity of MASLD in patients with type 2 diabetes mellitus in Kuwait.Frontiers in endocrinology
Investigating the regulatory potential of interval training and IPA supplementation on modulating the hepatic gluconeogenesis pathway in rats with non-alcoholic fatty liver disease.BMC gastroenterology
Cognitive impairment in metabolic dysfunction-associated steatotic liver disease ‒ Clinical evidence, liver-brain mechanisms and research priorities.Revista espanola de enfermedades digestivas
ÁttekintésFructose-related metabolic stress in MASLD: integrating intestinal substrate partitioning, hepatic phosphorus metabolite dynamics, and the inflammatory-fibrotic interface.Frontiers in medicine
A Minimally Invasive Diagnostic Platform Compatible with Tissue and Serum Analysis for Early Detection of Non-Alcoholic Fatty Liver Disease.Analytical chemistry
Joint effects of phenotypic age acceleration and novel insulin resistance indicators on mortality in adults with metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.Cardiovascular diabetology
Metabolic dysfunction-associated steatotic liver disease: Delphi consensus with specialists on comprehensive approach, public health policies, and primary care physicians' perspectives.Gaceta medica de Mexico
Machine learning-based prediction of non-alcoholic fatty liver disease in Chinese perimenopausal women: a retrospective observational study.BMJ open
Changing etiological spectrum and the rise of metabolic risk in liver cancer burden in China (1990-2021) with projections to 2036: a decomposition analysis based on the GBD 2021 study.BMC cancer
An Enzyme-Triggered Self-Immobilizing Dual-Modal Probe for Precision Imaging and Sustained Gas Therapy of Early-Stage MASH.Analytical chemistry
ÁttekintésPredicting response to GLP-1-based therapy in MASLD/MASH: an evidence-tiered, endpoint-specific framework built on host genotype and gut microbial features.Frontiers in endocrinology
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 48-week results from a multicentre, randomised, double-blind, phase 2b study.The lancet. Gastroenterology & hepatology
Associations of cumulative exposure and dynamic trajectories of the normalized creatinine-to-cystatin C ratio with incident cardiovascular disease in middle-aged and older Chinese adults with metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study.BMC cardiovascular disorders
Biological sex modifies the link between nutrient intake and metabolic dysfunction-associated steatotic liver disease: intrinsic oxidative vulnerability in females.Journal of the Endocrine Society
GLP-1-based Therapies in MASH: From Metabolic Benefits to an Improvement in Liver Fibrosis.Internal medicine (Tokyo, Japan)
Szisztematikus áttekintésPolyamine Dysregulation in Metabolic Dysfunction-associated Steatotic Liver Disease: a Systematic Review of Human Observational Evidence.Current obesity reports